Fundraising FoxRekindle Therapeutics
Cambridge, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into Rekindle Therapeutics
Sign up to see every warm intro you have to Rekindle Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rekindle Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2018
▶$1.1MraisedNov 2018 · 4 investors · BiotechnologyRule 506(b)
▶$1.1MraisedNov 2018 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Detlev BiniszkiewiczExecutive Officer, Director
- Ed HurwitzDirector
- Bard GeesamanDirector
- Offering amount
- $6.5M
- Amount sold
- $1.1M
- Minimum investment
- $10K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Rekindle Therapeutics's investors?
- Rekindle Therapeutics's investors include MPM BioImpact.
- How much funding has Rekindle Therapeutics raised?
- Rekindle Therapeutics has disclosed $1.1M raised across 1 round.
- Where is Rekindle Therapeutics headquartered?
- Rekindle Therapeutics is headquartered in Cambridge, US.